{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T13:13:32Z","timestamp":1777814012995,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011769","name":"Scripps Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI125626"],"award-info":[{"award-number":["AI125626"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI128556"],"award-info":[{"award-number":["AI128556"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["29888"],"award-info":[{"award-number":["29888"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.antiviral.2019.104667","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T02:22:19Z","timestamp":1574907739000},"page":"104667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity"],"prefix":"10.1016","volume":"173","author":[{"given":"Beatrice","family":"Cubitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Ortiz-Riano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benson YH.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles D.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine Z.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.O.E.","family":"Southall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Martinez-Sobrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104667_bib1","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1128\/JVI.77.15.8181-8186.2003","article-title":"Host factors in positive-strand RNA virus genome replication","volume":"77","author":"Ahlquist","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104667_bib2","series-title":"Genetic Landscape of Electron Transport Chain Complex I Dependency in Acute Myeloid Leukemia","author":"Baccelli IG","year":"2019"},{"key":"10.1016\/j.antiviral.2019.104667_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/v11030293","article-title":"Autophagy Promotes Infectious Particle Production of Mopeia and Lassa Viruses","volume":"vol. 11","author":"Baillet","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104667_bib4","first-page":"6","article-title":"[Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates]","volume":"10","author":"Battegay","year":"1993","journal-title":"ALTEX"},{"key":"10.1016\/j.antiviral.2019.104667_bib5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/657315","article-title":"Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever","volume":"51","author":"Bausch","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104667_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yapd.2009.08.007","article-title":"Lymphocytic choriomeningitis virus: a prenatal and postnatal threat","volume":"56","author":"Bonthius","year":"2009","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.antiviral.2019.104667_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.spen.2012.02.002","article-title":"Lymphocytic choriomeningitis virus: an underrecognized cause of neurologic disease in the fetus, child, and adult","volume":"19","author":"Bonthius","year":"2012","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.antiviral.2019.104667_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.spen.2012.03.001","article-title":"Viral Infections of the pediatric nervous system. Introduction","volume":"19","author":"Bonthius","year":"2012","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.antiviral.2019.104667_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00151-11","article-title":"Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins","volume":"2","author":"Bortz","year":"2011","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2019.104667_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.coi.2005.05.001","article-title":"Pathogenesis of viral hemorrhagic fever","volume":"17","author":"Bray","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2019.104667_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20140620","article-title":"Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria","volume":"462","author":"Bridges","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2019.104667_bib12","first-page":"1792","article-title":"Arenaviridae: the viruses and their replication","volume":"vol. 2","author":"Buchmeier","year":"2007"},{"key":"10.1016\/j.antiviral.2019.104667_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/v10110655","article-title":"Recombinant Lassa virus expressing green fluorescent protein as a tool for high-throughput drug screens and neutralizing antibody assays","volume":"10","author":"Cai","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104667_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2011.02.012","article-title":"Evaluation of Lassa antiviral compound ST-193 in a Guinea pig model","volume":"90","author":"Cashman","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104667_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-0348-8012-1_4","article-title":"Quasispecies and the development of new antiviral strategies","volume":"60","author":"Domingo","year":"2003","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.antiviral.2019.104667_bib16","volume":"vol. 299","author":"Domingo","year":"2006"},{"key":"10.1016\/j.antiviral.2019.104667_bib17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.virol.2011.01.013","article-title":"Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies","volume":"411","author":"Emonet","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104667_bib18","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/JVI.02102-10","article-title":"Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease","volume":"85","author":"Emonet","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104667_bib19","first-page":"865","article-title":"Emerging infectious diseases and risk to the traveler","volume":"83","author":"Freedman","year":"1999","journal-title":"Med. Clin. N. Am."},{"key":"10.1016\/j.antiviral.2019.104667_bib20","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2019.104667_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002614","article-title":"Favipiravir (T-705) inhibits Junin virus infection and reduces mortality in a Guinea pig model of Argentine hemorrhagic fever","volume":"7","author":"Gowen","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104667_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10408360490497456","article-title":"Lassa virus","volume":"41","author":"Gunther","year":"2004","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.antiviral.2019.104667_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.antiviral.2004.05.001","article-title":"Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro","volume":"63","author":"Gunther","year":"2004","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104667_bib24","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3201\/eid1612.100994","article-title":"Ribavirin for Lassa fever postexposure prophylaxis","volume":"16","author":"Hadi","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104667_bib25","doi-asserted-by":"crossref","first-page":"13793","DOI":"10.1128\/JVI.78.24.13793-13803.2004","article-title":"Replicon system for Lassa virus","volume":"78","author":"Hass","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104667_bib26","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1073\/pnas.1101143108","article-title":"Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis","volume":"108","author":"Hoffmann","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104667_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001862","article-title":"The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics","volume":"3","author":"Huang","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2019.104667_bib28","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries","volume":"103","author":"Inglese","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104667_bib29","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1086\/322620","article-title":"Viral hemorrhagic fever hazards for travelers in Africa","volume":"33","author":"Isaacson","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104667_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1087057105285610","article-title":"A comparison of assay performance measures in screening assays: signal window, Z' factor, and assay variability ratio","volume":"11","author":"Iversen","year":"2006","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2019.104667_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02256-17","article-title":"A highly conserved leucine in mammarenavirus matrix Z protein is required for Z interaction with the virus L polymerase and Z stability in cells harboring an active viral ribonucleoprotein","volume":"92","author":"Iwasaki","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104667_bib32","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1128\/JVI.00103-15","article-title":"Efficient interaction between arenavirus nucleoprotein (NP) and RNA-dependent RNA polymerase (L) is mediated by the virus nucleocapsid (NP-RNA) template","volume":"89","author":"Iwasaki","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104667_bib33","doi-asserted-by":"crossref","first-page":"12166","DOI":"10.1128\/JVI.02075-15","article-title":"General molecular strategy for development of arenavirus live-attenuated vaccines","volume":"89","author":"Iwasaki","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104667_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006892","article-title":"Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+\/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses","volume":"14","author":"Iwasaki","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104667_bib35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/biot.201200364","article-title":"Evaluating the influence of selection markers on obtaining selected pools and stable cell lines in human cells","volume":"8","author":"Lanza","year":"2013","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.antiviral.2019.104667_bib36","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/JVI.74.8.3470-3477.2000","article-title":"NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs","volume":"74","author":"Lee","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104667_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006859115450","article-title":"Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides","volume":"174","author":"Loffler","year":"1997","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.antiviral.2019.104667_bib38","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3851\/IMP1884","article-title":"Narasin, a novel antiviral compound that blocks dengue virus protein expression","volume":"16","author":"Low","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2019.104667_bib39","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.chembiol.2011.08.009","article-title":"Mitochondrial electron transport chain complex III is required for antimycin A to inhibit autophagy","volume":"18","author":"Ma","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.antiviral.2019.104667_bib40","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3201\/eid1808.120212","article-title":"Solid organ transplant-associated lymphocytic choriomeningitis, United States, 2011","volume":"18","author":"Macneil","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104667_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1432-1033.1996.0201u.x","article-title":"Catalytic activity of complex I in cell lines that possess replacement mutations in the ND genes in Leber's hereditary optic neuropathy","volume":"239","author":"Majander","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.antiviral.2019.104667_bib42","doi-asserted-by":"crossref","first-page":"e1342","DOI":"10.1371\/journal.pntd.0001342","article-title":"Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever","volume":"5","author":"Mendenhall","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104667_bib43","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/AAC.01219-10","article-title":"T-705 (favipiravir) inhibition of arenavirus replication in cell culture","volume":"55","author":"Mendenhall","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104667_bib44","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/acsinfecdis.7b00236","article-title":"Mining a krohnke pyridine library for anti-arenavirus activity","volume":"4","author":"Miranda","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104667_bib45","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/JVI.02275-13","article-title":"Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor","volume":"88","author":"Ortiz-Riano","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104667_bib46","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa073785","article-title":"A new arenavirus in a cluster of fatal transplant-associated diseases","volume":"358","author":"Palacios","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.104667_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082318","article-title":"Discovery of potent broad spectrum antivirals derived from marine actinobacteria","volume":"8","author":"Raveh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104667_bib48","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","article-title":"Lassa fever: epidemiology, clinical features, and social consequences","volume":"327","author":"Richmond","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.antiviral.2019.104667_bib49","doi-asserted-by":"crossref","first-page":"14775","DOI":"10.1038\/srep14775","article-title":"The broad-spectrum antiviral favipiravir protects Guinea pigs from lethal Lassa virus infection post-disease onset","volume":"5","author":"Safronetz","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104667_bib50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-virology-101416-042001","article-title":"New world arenavirus biology","volume":"4","author":"Sarute","year":"2017","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.antiviral.2019.104667_bib51","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nmeth819","article-title":"A guide to choosing fluorescent proteins","volume":"2","author":"Shaner","year":"2005","journal-title":"Nat. Methods"},{"key":"10.1016\/j.antiviral.2019.104667_bib52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1101\/pdb.ip067876","article-title":"Design and construction of 2A peptide-linked multicistronic vectors","volume":"2012","author":"Szymczak-Workman","year":"2012","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.antiviral.2019.104667_bib53","article-title":"Antiviral activity of a small molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease","author":"Urata","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104667_bib54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1875397301004010057","article-title":"A grid algorithm for high throughput fitting of dose-response curve data","volume":"4","author":"Wang","year":"2010","journal-title":"Curr. Chem. Genom."},{"key":"10.1016\/j.antiviral.2019.104667_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2016.10.007","article-title":"Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems","volume":"136","author":"Welch","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104667_bib56","doi-asserted-by":"crossref","first-page":"10012","DOI":"10.1073\/pnas.0403596101","article-title":"Small molecules targeting severe acute respiratory syndrome human coronavirus","volume":"101","author":"Wu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104667_bib57","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1128\/JVI.01433-13","article-title":"Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus","volume":"87","author":"Yun","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104667_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219305170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219305170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:11:24Z","timestamp":1777497084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219305170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":58,"alternative-id":["S0166354219305170"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104667","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104667"}}